TY - JOUR
T1 - Multimodality treatment with surgery for locally advanced non-small-cell lung cancer with n2 disease
T2 - A review article
AU - Toyokawa, Gouji
AU - Takenoyama, Mitsuhiro
AU - Ichinose, Yukito
N1 - Publisher Copyright:
© 2015 Elsevier Inc. All rights reserved.
PY - 2015/1/1
Y1 - 2015/1/1
N2 - Stage III non-small-cell lung cancer (NSCLC) is composed of a heterogeneous population of lesions (ie, T4N0-3, T3N1-3, and T1a-2aN2-3), which makes it difficult to establish a definitive treatment strategy. Although several retrospective and prospective studies have been conducted to investigate the significance of multimodality treatments with surgery for patients with resectable stage III NSCLC, the role of surgery still remains controversial. In this article, we review the results of retrospective and prospective studies that have investigated the significance of multimodality treatment with surgery for patients with stage III NSCLC, particularly those with mediastinal lymph node metastasis, and the implications for the treatment of this controversial subset of patients.
AB - Stage III non-small-cell lung cancer (NSCLC) is composed of a heterogeneous population of lesions (ie, T4N0-3, T3N1-3, and T1a-2aN2-3), which makes it difficult to establish a definitive treatment strategy. Although several retrospective and prospective studies have been conducted to investigate the significance of multimodality treatments with surgery for patients with resectable stage III NSCLC, the role of surgery still remains controversial. In this article, we review the results of retrospective and prospective studies that have investigated the significance of multimodality treatment with surgery for patients with stage III NSCLC, particularly those with mediastinal lymph node metastasis, and the implications for the treatment of this controversial subset of patients.
UR - http://www.scopus.com/inward/record.url?scp=84927564704&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84927564704&partnerID=8YFLogxK
U2 - 10.1016/j.cllc.2014.07.007
DO - 10.1016/j.cllc.2014.07.007
M3 - Review article
C2 - 25220209
AN - SCOPUS:84927564704
SN - 1525-7304
VL - 16
SP - 6
EP - 14
JO - Clinical Lung Cancer
JF - Clinical Lung Cancer
IS - 1
ER -
